Hematological Malignancies
Showing NaN - NaN of 5
Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination
Active, not recruiting
- Pediatric Cancer
- +2 more
- Durvalumab / Tremelimumab Combination Therapy
-
Baltimore, Maryland
- +18 more
Nov 3, 2022
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020